Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
T-TAS 01 HD Assay
Locations
6
United States
San Francisco General Hospital
San Francisco, California, United States
University of Colorado Anschutz Medical Campus
Denver, Colorado, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Duke University
Durham, North Carolina, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
Start Date
September 25, 2023
Primary Completion Date
June 30, 2025
Completion Date
June 30, 2025
Last Updated
July 28, 2025
NCT05070845
NCT07039422
NCT06533098
NCT07007962
NCT07492693
NCT07048249
Lead Sponsor
Hikari Dx, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions